Carnomed sp. z o.o.

Other retail sale in non-specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-07-14
Share capital
5,000.00 PLN
Activity description

Carnomed Polska produces dietary supplements, including KARNOZIN extra and CreGAAtine. The company emphasizes natural ingredients, ISO and HACCP-compliant production, and its own R&D research with the Medical University of Novi Sad. It also offers consultations on supplement use and a 10% discount through the Large Family Card program.

Registered address
ul. Dolnych Młynów 3/1, 31-124 Kraków, Poland
Email
Phone
Social media

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements were filed late (the longest delay 10 days for 2023).

  • 2025not filed
  • 202422/07/2025
  • 202325/07/2024
  • 202229/06/2023
  • 202111/07/2022
  • 202001/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Top 76%
Top 68%
Voivodeship · Małopolskie32,115 / 46,048
Top 70%
Country · Poland349,669 / 496,474
Top 70%

Results vs industry

Revenue
This companyUSD 40.22kMedianUSD 235.17kAverageUSD 17.30m
Net profit
This companyUSD 13.89kMedianUSD 4.03kAverageUSD 502.07k
Operating costs
This companyUSD 25.41kMedianUSD 224.05kAverageUSD 16.27m
Assets
This companyUSD 13.76kMedianUSD 143.94kAverageUSD 5.35m

Offer

  • Dietary supplements
  • Carnosine products
  • Coenzyme Q10 products
  • Creatine products
  • Supplement consultations
  • Scientific research on ingredients
Certifications: HACCP

Websites

  • carno-med.plCarnomed Polska | Suplementy diety, sprawne mitochondria
    WordPress 6.9Google Tag ManagerYoast SEOApache
  • cregaatine.plCreGAAtine — kreatyna + GAA, skuteczniejsza niż monohydrat
    WordPress 7.1Google Tag ManagerYoast SEOApache

Authorized Representatives

Anna Maria Sobczak age 43 – President of the Management Board
Michał Sobczak age 47 – Vice President of the Management Board

Manner of representation

To make declarations of will on behalf of the company up to the amount of PLN 20,000.00, the President of the Management Board and the Vice-President are authorised to act independently. Above the amount of PLN 20,000.00, the President of the Management Board and the Vice-President acting jointly, the President of the Management Board acting jointly with a member of the management board, or the Vice-President acting jointly with a member of the management board are authorised to make declarations of will on behalf of the company. To make non-property declarations of will on behalf of the company, the joint action of two members of the management board or one member jointly with a commercial proxy is required.

Ownership

OwnerSharesShare valueStake
25$675.3150%
25$675.3150%

Anna Maria Sobczak and Michał Sobczak hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2018-10-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $11,830.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,741
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$3,789
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$4,017

Competitors

Name
Micare Poland sp. z o.o.
A-Medica sp. z o.o.
Zielarnia Franciszkańska sp. z o.o.
PRO Aktiv sp. z o.o.
Przedsiębiorstwo Produkcyjno-Handlowe Varia sp. z o.o.
RESQ Lab sp. z o.o.
Leenlife Pharma S.A.
Cannpharm sp. z o.o.
Vitalic Europe sp. z o.o.
Amaderm sp. z o.o.

Change history

DateEvent
2023-02-14Address change
2018-02-21Address change
2017-07-14Entered in the register

FAQ

Last updated: 2026-05-29